224 related articles for article (PubMed ID: 19237510)
1. Generation of the human metabolite piceatannol from the anticancer-preventive agent resveratrol by bacterial cytochrome P450 BM3.
Kim DH; Ahn T; Jung HC; Pan JG; Yun CH
Drug Metab Dispos; 2009 May; 37(5):932-6. PubMed ID: 19237510
[TBL] [Abstract][Full Text] [Related]
2. Generation of human metabolites of 7-ethoxycoumarin by bacterial cytochrome P450 BM3.
Kim DH; Kim KH; Kim DH; Liu KH; Jung HC; Pan JG; Yun CH
Drug Metab Dispos; 2008 Nov; 36(11):2166-70. PubMed ID: 18669587
[TBL] [Abstract][Full Text] [Related]
3. Highly regioselective hydroxylation of polydatin, a resveratrol glucoside, for one-step synthesis of astringin, a piceatannol glucoside, by P450 BM3.
Le TK; Jang HH; Nguyen HT; Doan TT; Lee GY; Park KD; Ahn T; Joung YH; Kang HS; Yun CH
Enzyme Microb Technol; 2017 Feb; 97():34-42. PubMed ID: 28010771
[TBL] [Abstract][Full Text] [Related]
4. Generation of human chiral metabolites of simvastatin and lovastatin by bacterial CYP102A1 mutants.
Kim KH; Kang JY; Kim DH; Park SH; Park SH; Kim D; Park KD; Lee YJ; Jung HC; Pan JG; Ahn T; Yun CH
Drug Metab Dispos; 2011 Jan; 39(1):140-50. PubMed ID: 20962060
[TBL] [Abstract][Full Text] [Related]
5. Regioselective hydroxylation of 17β-estradiol by mutants of CYP102A1 from Bacillus megaterium.
Cha GS; Ryu SH; Ahn T; Yun CH
Biotechnol Lett; 2014 Dec; 36(12):2501-6. PubMed ID: 25129047
[TBL] [Abstract][Full Text] [Related]
6. Engineering bacterial cytochrome P450 (P450) BM3 into a prototype with human P450 enzyme activity using indigo formation.
Park SH; Kim DH; Kim D; Kim DH; Jung HC; Pan JG; Ahn T; Kim D; Yun CH
Drug Metab Dispos; 2010 May; 38(5):732-9. PubMed ID: 20100815
[TBL] [Abstract][Full Text] [Related]
7. Application of engineered cytochrome P450 mutants as biocatalysts for the synthesis of benzylic and aromatic metabolites of fenamic acid NSAIDs.
Venkataraman H; Verkade-Vreeker MC; Capoferri L; Geerke DP; Vermeulen NP; Commandeur JN
Bioorg Med Chem; 2014 Oct; 22(20):5613-20. PubMed ID: 24999003
[TBL] [Abstract][Full Text] [Related]
8. Regioselective hydroxylation of omeprazole enantiomers by bacterial CYP102A1 mutants.
Ryu SH; Park BY; Kim SY; Park SH; Jung HJ; Park M; Park KD; Ahn T; Kang HS; Yun CH
Drug Metab Dispos; 2014 Sep; 42(9):1493-7. PubMed ID: 25008345
[TBL] [Abstract][Full Text] [Related]
9. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
[TBL] [Abstract][Full Text] [Related]
10. An Enzymatic Route to α-Tocopherol Synthons: Aromatic Hydroxylation of Pseudocumene and Mesitylene with P450 BM3.
Dennig A; Weingartner AM; Kardashliev T; Müller CA; Tassano E; Schürmann M; Ruff AJ; Schwaneberg U
Chemistry; 2017 Dec; 23(71):17981-17991. PubMed ID: 28990705
[TBL] [Abstract][Full Text] [Related]
11. Hydroxylation of non-substituted polycyclic aromatic hydrocarbons by cytochrome P450 BM3 engineered by directed evolution.
Sideri A; Goyal A; Di Nardo G; Tsotsou GE; Gilardi G
J Inorg Biochem; 2013 Mar; 120():1-7. PubMed ID: 23262457
[TBL] [Abstract][Full Text] [Related]
12. Screening of a minimal enriched P450 BM3 mutant library for hydroxylation of cyclic and acyclic alkanes.
Weber E; Seifert A; Antonovici M; Geinitz C; Pleiss J; Urlacher VB
Chem Commun (Camb); 2011 Jan; 47(3):944-6. PubMed ID: 21079837
[TBL] [Abstract][Full Text] [Related]
13. Desaturation of alkylbenzenes by cytochrome P450(BM3) (CYP102A1).
Whitehouse CJ; Bell SG; Wong LL
Chemistry; 2008; 14(35):10905-8. PubMed ID: 19003834
[No Abstract] [Full Text] [Related]
14. Active site substitution A82W improves the regioselectivity of steroid hydroxylation by cytochrome P450 BM3 mutants as rationalized by spin relaxation nuclear magnetic resonance studies.
Rea V; Kolkman AJ; Vottero E; Stronks EJ; Ampt KA; Honing M; Vermeulen NP; Wijmenga SS; Commandeur JN
Biochemistry; 2012 Jan; 51(3):750-60. PubMed ID: 22208729
[TBL] [Abstract][Full Text] [Related]
15. Stereoselective hydroxylation of isophorone by variants of the cytochromes P450 CYP102A1 and CYP101A1.
Dezvarei S; Lee JHZ; Bell SG
Enzyme Microb Technol; 2018 Apr; 111():29-37. PubMed ID: 29421034
[TBL] [Abstract][Full Text] [Related]
16. Glutamate-haem ester bond formation is disfavoured in flavocytochrome P450 BM3: characterization of glutamate substitution mutants at the haem site of P450 BM3.
Girvan HM; Levy CW; Williams P; Fisher K; Cheesman MR; Rigby SE; Leys D; Munro AW
Biochem J; 2010 Apr; 427(3):455-66. PubMed ID: 20180779
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the oxidation of short chain alkynes by flavocytochrome P450 BM3.
Waltham TN; Girvan HM; Butler CF; Rigby SR; Dunford AJ; Holt RA; Munro AW
Metallomics; 2011 Apr; 3(4):369-78. PubMed ID: 21431175
[TBL] [Abstract][Full Text] [Related]
18. Flavocytochrome P450 BM3 mutant W1046A is a NADH-dependent fatty acid hydroxylase: implications for the mechanism of electron transfer in the P450 BM3 dimer.
Girvan HM; Dunford AJ; Neeli R; Ekanem IS; Waltham TN; Joyce MG; Leys D; Curtis RA; Williams P; Fisher K; Voice MW; Munro AW
Arch Biochem Biophys; 2011 Mar; 507(1):75-85. PubMed ID: 20868649
[TBL] [Abstract][Full Text] [Related]
19. Expression of Synthetic cyp102A1-LG23 Gene and Functional Analysis of Recombinant Cytochrome P450 BM3-LG23 in the Actinobacterium Mycolicibacterium smegmatis.
Poshekhontseva VY; Strizhov NI; Karpov MV; Nikolaeva VM; Kazantsev AV; Sazonova OI; Shutov AA; Donova MV
Biochemistry (Mosc); 2023 Sep; 88(9):1347-1355. PubMed ID: 37770401
[TBL] [Abstract][Full Text] [Related]
20. The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1.
Potter GA; Patterson LH; Wanogho E; Perry PJ; Butler PC; Ijaz T; Ruparelia KC; Lamb JH; Farmer PB; Stanley LA; Burke MD
Br J Cancer; 2002 Mar; 86(5):774-8. PubMed ID: 11875742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
